[1] PAN Y,LI P,JIA R,et al.Regulation of apoptosis during porcine circovirus type 2 infection[J].Frontiers in Microbiology,2018,9(1):2086-2098.
[2] 于静,陈彦永,何小江,等.猪圆环病毒2型巢式PCR检测方法的建立与初步应用[J].中国畜牧兽医,2015,42(12):3173-3178. YU J,CHEN Y Y,HE X J,et al.Establishment and preliminary application of nested PCR for the detection of porcine circovirus type 2[J].China Animal Husbandry & Veterinary Medicine,2015,42(12):3173-3178.(in Chinese)
[3] NEIRA V,RAMOS N,TAPIA R,et al.Genetic analysis of porcine circovirus type 2 from pigs affected with PMWS in Chile reveals intergenotypic recombination[J].Journal of Virology,2017,14(1):191-197.
[4] LI P C,QIAO X W,ZHENG Q S,et al.Immunogenicity and immunoprotection of porcine circovirus type 2(PCV2) Cap protein displayed by Lactococcus lactis[J].Vaccine,2016,34(5):696-702.
[5] 李富强,王利丽,李秀丽,等.猪圆环病毒2型分子生物学研究进展[J].天津农业科学,2015,21(9):57-60. LI F Q,WANG L L,LI X L,et al.Progress on molecular biology of PCV2[J].Tianjin Agricultural Sciences,2015,21(9):57-60.(in Chinese)
[6] 高田,张丽琳,黄金海,等.PCV2病毒样颗粒疫苗的研究进展[J].生命的化学,2017,37(2):233-238. GAO T,ZHANG L L,HUANG J H,et al.Progress on porcine circovirus type 2 virus-like particle[J].Chemisty of Life,2017,37(2):233-238.(in Chinese)
[7] 侯强,侯绍华,贾红,等.猪圆环病毒2d亚型病毒样颗粒的制备与鉴定[J].中国兽医科学,2017,47(11):1385-1391. HOU Q,HOU S H,JIA H,et al.Preparation and identification of porcine circovirus type 2d Cap protein as virus-like particles in insect cells[J].Chinese Veterinary Science,2017,47(11):1385-1391.(in Chinese)
[8] GARG H,SEDANO M,PLATA G,et al.Development of virus-like particle vaccine and reporter assay for Zika virus[J].Journal of Virology,2017,91(20):e00834-17.
[9] 赵晓云,乔绪稳,陈瑾,等.利用E.coli表达猪圆环病毒2型Cap蛋白生产病毒样颗粒疫苗[J].中国农业科学,2015,48(5):976-986. ZHAO X Y,QIAO X W,CHEN J,et al.PCV2 virus like particles vaccine produced with recombinant Cap protein expressed in E.coli[J].Scientia Agricultura Sinica,2015,48(5):976-986.(in Chinese)
[10] NAINYS J,LASICKIENE R,PETRAITYTE-BURNEIKIENE R,et al.Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies[J].BioMed Central Biotechnology,2014,14(1):100-110.
[11] HUANG X,WANG X,ZHANG J,et al.Escherichia coli-derived virus-like particles in vaccine develop-ment[J].NPJ Vaccines,2017,2(1):3-11.
[12] WU P C,LIN W L,WU C M,et al.Characterization of porcine circovirus type 2(PCV2) capsid particle assembly and its application to virus-like particle vaccine development[J].Applied Microbiology and Biotechnology,2012,95(6):1501-1507.
[13] 于孟冉.超大孔色谱纯化类病毒颗粒的过程研究[D].北京:中国科学院,2015. YU M R.Study on gigaporous chromatographic process of virus-like particles purification[D].Beijing:Chinese Academy of Sciences,2015.(in Chinese)
[14] QUAN F S,LEE Y T,KIM K H,et al.Progress in developing virus-like particle influenza vaccines[J].Expert Review of Vaccines,2016,15(10):1281-1293.
[15] 杨剑,尹丹,罗文涓,等.猪圆环病毒2型诱导小鼠体内免疫细胞氧化胁迫模型的建立[J].中国畜牧兽医,2017,44(2):402-410. YANG J,YIN D,LUO W J,et al.Establishment of model for oxidative stress in mice immune cells induced by PCV2 in vivo[J].China Animal Husbandry & Veterinary Medicine,2017,44(2):402-410.(in Chinese)
[16] LÓPEZ-VIDAL J,GÓMEZ-SEBASTIÁN S,BÁRCENA J,et al.Improved production efficiency of virus-like particles by the baculovirus expression vector system[J].Public Library of Science One,2015,10(10):39-51.
[17] 余婉婷,湛洋,雷昕诺,等.猪圆环病毒2型病毒样颗粒的研究及应用[J].中国畜牧兽医文摘,2015,31(5):57-67. YU W T,ZHAN Y,LEI X N,et al.Study and application of porcine circovirus type 2 virus-like particles[J].Chinese Abstracts of Animal Husbandry and Veterinary Medicine,2015,31(5):57-67.(in Chinese)
[18] ZHOU J Y,SHANG S B,GONG H,et al.In vitro expression,monoclonal antibody and bioactivity for capsid protein of porcine circovirus type Ⅱ without nuclear localization signal[J].Journal of Biotechnology,2005,118(2):201-211.
[19] KONG W T,KONG J,HU S M,et al.Enhanced expression of PCV2 capsid protein in Escherichia coli and Lactococcus lactis by codon optimization[J].World Journal of Microbiology Biotechnology,2011,27(3):651-657.
[20] MOHSEN M O,ZHA L,CABRAL-MIRANDA G,et al.Major findings and recent advances in virus-like particle (VLP)-based vaccines[J].Seminars in Immunology,2017,34(1):123-132.
[21] WU P C,CHEN T Y,CHI J N,et al.Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli[J].Journal of Biotechnology,2016,220:78-85.
[22] ANGELO J M,LENHOFF M.Determinants of protein elution rates from preparative ion exchange adsorbents[J].Journal of Chromatography A,2016,1440(1):94-104.
[23] 杨延丽.灭活病毒及病毒样颗粒的结构表征和稳定性研究[D].北京:中国科学院,2015. YANG Y L.Characterization and stabilization of inactivated virus and virus like particles[D].Beijing:Chinese Academy of Sciences,2015.(in Chinese)
[24] CHEN Y,ZHANG Y,QUAN C,et al.Aggregation and antigenicity of virus like particle in salt solution-A case study with hepatitis B surface antigen[J].Vaccine,2015,33(35):4300-4306.
[25] HUANG Y,BI J,ZHANG Y,et al.A highly efficient integrated chromatographic procedure for the purification of recombinant hepatitis B surface antigen from Hansenula polymorpha[J].Protein Expression and Purification,2007,56(2):301-310.
[26] SANCHEZ-RODRIGUEZ S P,MUNCH-ANGUIANO L,ECHEVERRIA O,et al.Human parvovirus B19 virus-like particles: In vitro assembly and stability[J].Biochimie,2012,94(3):870-878. |